These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14997903)

  • 1. Institutional Review Board (IRB) is accused of serious non-compliance.
    Maloney DM
    Hum Res Rep; 2004 Jan; 19(1):8. PubMed ID: 14997903
    [No Abstract]   [Full Text] [Related]  

  • 2. Case study: research subject says institutional review board (IRB) was no help.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):7. PubMed ID: 16789306
    [No Abstract]   [Full Text] [Related]  

  • 3. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 5. Recruiting human subjects without IRB review/approval.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
    [No Abstract]   [Full Text] [Related]  

  • 6. Research subject complains about how she was treated by an institutional review board (IRB).
    Maloney DM
    Hum Res Rep; 2005 Dec; 20(12):7. PubMed ID: 16607709
    [No Abstract]   [Full Text] [Related]  

  • 7. Case study: research subject says institutional review board (IRB) would not answer her questions.
    Maloney DM
    Hum Res Rep; 2006 Feb; 21(2):7. PubMed ID: 16789309
    [No Abstract]   [Full Text] [Related]  

  • 8. Case study: agency says institutional review board (IRB) did not fulfill duties so agency investigation expands.
    Maloney DM
    Hum Res Rep; 2006 Apr; 21(4):6-7. PubMed ID: 16832919
    [No Abstract]   [Full Text] [Related]  

  • 9. Case study: institutional review board (IRB) did not know about subject problem until after study.
    Maloney DM
    Hum Res Rep; 2006 May; 21(5):6-7. PubMed ID: 16832916
    [No Abstract]   [Full Text] [Related]  

  • 10. The globalization of clinical trials: a growing challenge in protecting human subjects: executive summary (2001).
    Department of Health and Human Services, Office of the Inspector General, USA
    J Int Bioethique; 2003; 14(1-2):165-9. PubMed ID: 15035253
    [No Abstract]   [Full Text] [Related]  

  • 11. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 12. Case study: agency says institutional review board (IRB) failed to warn subjects of significant problems.
    Maloney DM
    Hum Res Rep; 2006 Mar; 21(3):6-7. PubMed ID: 16789303
    [No Abstract]   [Full Text] [Related]  

  • 13. Data from human research projects will now be available to public.
    Maloney DM
    Hum Res Rep; 2001 Apr; 16(4):1-2. PubMed ID: 11883453
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Court refuses to interfere with institutional review board (IRB).
    Maloney DM
    Hum Res Rep; 2003 Apr; 18(4):8. PubMed ID: 14603945
    [No Abstract]   [Full Text] [Related]  

  • 16. Researchers break the rules in frustration at review boards.
    Giles J
    Nature; 2005 Nov; 438(7065):136-7. PubMed ID: 16280994
    [No Abstract]   [Full Text] [Related]  

  • 17. Institutional conflicts of interest and research with human subjects.
    Maloney DM
    Hum Res Rep; 2003 Feb; 18(2):1-2. PubMed ID: 12814111
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigational drugs and research.
    Tueting P
    Psychiatr Med; 1991; 9(2):333-47. PubMed ID: 1857767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At your own risk. Some patients join clinical trials out of desperation, others to help medicine advance. Who is to blame if they get sick--or even die?
    Lemonick MD; Goldstein A
    Time; 2002 Apr; 159(16):46-56. PubMed ID: 11974609
    [No Abstract]   [Full Text] [Related]  

  • 20. Agency proposes safeguards for children in clinical trials.
    Maloney DM
    Hum Res Rep; 2006 Jun; 21(6):1-2. PubMed ID: 17111531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.